Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2246)	2/11/2008 5:55:38 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

DDSS was up 18.10% at its intraday H & still was able to close up 15.52%, but it isn't doing well AHs. The stock has continued its near term UT that started on Jan 24 from the $0.95 level, with some pause at the $2 <g> Today's volume of 541,591 was about 4x its ADV bigcharts.marketwatch.com On Friday it announced that its recently completed PIII of trazodone achieved statistical significance for the primary efficacy endpoint & also demonstrated improved patient sleep patterns.It plans to file an NDA for its 1x daily formulation of trazodone with the FDA later this year. Trazodone is an atypical anti-depressant that acts as a dual serotonin agonist and serotonin reuptake inhibitor.It appears to increase serotonin activity by 3 mechanisms: the activation of neuronal serotonin receptors; the inhibition at the neuronal serotonin feedback system which regulates the action of serotonin; & the inhibition of the re-uptake of serotonin. DDSS is trying to optimize the performance of existing small molecule drugs using its controlled-release technologies.Its lead product, is a 1x daily formulation of tramadol,which is already being launched globally. The insiders hold < 5% & institutions around 10%. The short ratio came down 15%, is around 1.2x its ADV & it probably has come down more so far this month.<g> If the stock can start closing some of its June 1 DG above the $3.20 level, it could still have further good % gains.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2246)	3/6/2008 12:07:28 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MITI Is again above the $1.50 level in spite of the general market.<g> bigcharts.marketwatch.com It announced today that it will host a CC on Thursday, March 13, at 9:00am, after releasing its 4th Q results at 7:00am MITI has been able to trim its losses in the last 2 Qs, but it seems that it will have a hard time to show better results in the pending 4thQ since last Yr it reported earning on the black at $0.11/shr vs. the loss of $0.13/shr in 2005. For 2007 the EL is around $0.60/shr vs. the $0.63/shr in 2006 & for 2008 another loss around $0.63/shr is expected. The insiders reportedly hold around 30%, The short ratio is around 8x its ADV Although the stock remains on a DT, it seems worth of keeping on a WL.<g> bigcharts.marketwatch.com Bernard